Moleculin Biotech, Inc.
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment …
Biotechnology
US, Houston [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Moleculin Biotech, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDMoleculin Biotech, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Moleculin Biotech, Inc..
If you want to see a demo, head over to the financial segments of AAPL